Latest Industry Projects

Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Bausch + Lomb

Valeant Pharmaceuticals International, Inc. announced it has completed the previously announced acquisition of Bausch + Lomb Holdings Incorporated. Bausch + Lomb is a leading global eye health company that has a broad portfolio of eye health products, including well-known prescription and OTC brands Besivance, Lotemax, Ocuvite and PreserVision; vision care brands Biotrue ONEday, PureVision, renu and Boston; and surgical brands enVista, Storz, Stellaris and VICTUS. About Valeant Pharmaceuticals International, Inc. Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics. More information about Valeant Pharmaceuticals International, Inc. http://valeant.q4web.com/investor-relations/news-releases/news-release-details/2013/Valeant-Pharmaceuticals-International-Inc-Completes-Acquisition-Of-Bausch--Lomb/default.aspx Project Name Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Bausch + Lomb Location Canada Commence 2013 Completion -NA- Estimated Investment -NA- Capacity -NA- Key Players Valeant Pharmaceuticals International, Inc.

Other Projects